Ergomed
Natalia Grassis currently serves as the Executive Vice President of Global Operations at ERGOMED, a position held since April 2024. Previously, Natalia held the role of EVP Global Clinical Operations and Delivery at Veristat from September 2022 to March 2024 and was the Vice President-Head of Clinical Operations at Freeline from February 2022 to September 2022, overseeing gene therapy programs for rare diseases. Natalia's extensive experience includes a decade at Parexel, where various roles included Corporate VP - Head of Biotech Americas East and Corporate VP Global Clinical Operations, focusing on developing novel therapies for biotech clients. Earlier career stages include significant positions at PPD from February 2002 to March 2012, culminating in roles such as Director of Global Monitoring Operations for Latin America. Natalia's academic background includes a Master's degree in Management from Universidad de Belgrano and dual Master's degrees in Biochemistry and Health from Universidad Nacional de Rosario.
This person is not in the org chart
This person is not in any offices
Ergomed
Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information.